From TokenPost · · 30s
TL;DR: Greenwich LifeSciences Shares Jump After Trial Poster News
Greenwich LifeSciences shares surged over 25% following Phase 3 cancer trial poster announcements.
Greenwich LifeSciences shares rose more than 25% after disclosing two FLAMINGO-01 Phase 3 cancer trial posters for an upcoming medical event. Greenwich LifeSciences shares surged over 25% following Phase 3 cancer trial poster announcements. Greenwich LifeSciences, Inc. shares rose more than 25% Tuesday, Nov. 17. The company disclosed two FLAMINGO-01 Phase 3 cancer trial posters for an upcoming medical event.
- Greenwich LifeSciences Shares
- Trial Poster Announcement
- Stock Trading Details
Read the story version — the same reporting as a swipeable deck of 3 cards.






